Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cardiometabolic risk burden is high in patients under 50 with type 2 diabetes

Key clinical point: Younger people with type 2 diabetes need a more focused treatment strategy, irrespective of cardiometabolic risk.

Major finding: People diagnosed with type 2 diabetes at 18-39 years of age had significantly higher cardiometabolic risk burden, compared with older people

Study details: Retrospective study of primary care electronic medical records from The Health Improvement Network database on 370,854 incident cases of type 2 diabetes occurring between 2000 and 2017.

Disclosures: Dr. Paul and Dr. Koye reported having no conflicts of interest.


Koye D et al. EASD 2019, Abstract 82.